ROY F CHEMALY

TitleProfessor
InstitutionMD Anderson
DepartmentInfectious Diseases, Infection Control, and Employee Health
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Angelidakis G, Khawaja F, Mulanovich VE, Garnes ND, Heredia EA, Chemaly RF. Combination of Baloxavir and Oseltamivir for Treatment of Severe Influenza Infection in Hematopoietic Cell Transplant Recipients: A Novel Treatment Strategy for a High-risk Population. Microbes Infect. 2021 Oct 28; 104895. PMID: 34756990.
      Citations:    Fields:    
    2. Sassine J, Khawaja F, Shigle TL, Handy V, Foolad F, Aitken SL, Jiang Y, Champlin R, Shpall E, Rezvani K, Ariza-Heredia EJ, Chemaly RF. Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era. Clin Infect Dis. 2021 10 20; 73(8):1346-1354. PMID: 33830182.
      Citations: 2     Fields:    Translation:HumansCells
    3. Yong MK, Shigle TL, Kim YJ, Carpenter PA, Chemaly RF, Papanicolaou GA. American Society for Transplantation and Cellular Therapy Series: #4 - Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation. Transplant Cell Ther. 2021 Sep 21. PMID: 34560310.
      Citations:    
    4. Chemaly RF, Marty FM, Wolfe CR, Lawrence SJ, Dadwal S, Soave R, Farthing J, Hawley S, Montanez P, Hwang J, Ho JH, Lewis S, Wang G, Boeckh M. DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study. Clin Infect Dis. 2021 08 02; 73(3):e773-e781. PMID: 33569576.
      Citations:    Fields:    Translation:HumansAnimalsCTClinical Trials
    5. Chemaly RF. The ever-growing world of infections in immunocompromised patients: major headways with numerous shortcomings. Clin Microbiol Infect. 2021 Oct; 27(10):1379-1380. PMID: 34256140.
      Citations:    Fields:    
    6. Goldsmith SR, Abid MB, Auletta JJ, Bashey A, Beitinjaneh A, Castillo P, Chemaly RF, Chen M, Ciurea S, Dandoy CE, Díaz MÁ, Fuchs E, Ganguly S, Kanakry CG, Kanakry JA, Kim S, Komanduri KV, Krem MM, Lazarus HM, Liu H, Ljungman P, Masiarz R, Mulroney C, Nathan S, Nishihori T, Page KM, Perales MA, Taplitz R, Romee R, Riches M. Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis. Blood. 2021 06 10; 137(23):3291-3305. PMID: 33657221.
      Citations: 5     Fields:    
    7. Ye X, Iwuchukwu OP, Avadhanula V, Aideyan LO, McBride TJ, Henke DM, Patel KD, Piedra FA, Angelo LS, Shah DP, Chemaly RF, Piedra PA. Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients. Viruses. 2021 May 26; 13(6). PMID: 34073490.
      Citations:    Fields:    
    8. Ong DSY, Fragkou PC, Schweitzer VA, Chemaly RF, Moschopoulos CD, Skevaki C. How to interpret and use COVID-19 serology and immunology tests. Clin Microbiol Infect. 2021 Jul; 27(7):981-986. PMID: 33975005.
      Citations: 4     Fields:    Translation:Humans
    9. Sharma A, Bhatt NS, St Martin A, Abid MB, Bloomquist J, Chemaly RF, Dandoy C, Gauthier J, Gowda L, Perales MA, Seropian S, Shaw BE, Tuschl EE, Zeidan AM, Riches ML, Shah GL. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol. 2021 Mar; 8(3):e185-e193. PMID: 33482113.
      Citations: 43     Fields:    Translation:Humans
    10. Gans H, Chemaly RF. Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program. BMC Infect Dis. 2021 Jan 11; 21(1):46. PMID: 33430796.
      Citations:    Fields:    Translation:HumansCells
    11. El Haddad L, Hanson BM, Arias CA, Ghantoji SS, Harb CP, Stibich M, Chemaly RF. Emergence and Transmission of Daptomycin and Vancomycin-Resistant Enterococci Between Patients and Hospital Rooms. Clin Infect Dis. 2021 Jan 09. PMID: 33421068.
      Citations:    Fields:    
    12. Chemaly RF, Dadwal SS, Bergeron A, Ljungman P, Kim YJ, Cheng GS, Pipavath SN, Limaye AP, Blanchard E, Winston DJ, Stiff PJ, Zuckerman T, Lachance S, Rahav G, Small CB, Mullane KM, Patron RL, Lee DG, Hirsch HH, Waghmare A, McKevitt M, Jordan R, Guo Y, German P, Porter DP, Gossage DL, Watkins TR, Marty FM, Chien JW, Boeckh M. A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients. Clin Infect Dis. 2020 12 31; 71(11):2777-2786. PMID: 31793991.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    13. Marty FM, Chemaly RF, Mullane KM, Lee DG, Hirsch HH, Small CB, Bergeron A, Shoham S, Ljungman P, Waghmare A, Blanchard E, Kim YJ, McKevitt M, Porter DP, Jordan R, Guo Y, German P, Boeckh M, Watkins TR, Chien JW, Dadwal SS. A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract. Clin Infect Dis. 2020 12 31; 71(11):2787-2795. PMID: 31915807.
      Citations: 10     Fields:    Translation:Humans
    14. Carpenter PA, Papanicolaou G, Chemaly RF, Boeckh M, Savani BN. American Society for Transplantation and Cellular Therapy Infectious Disease Guidelines: Preface to the Series. Transplant Cell Ther. 2021 02; 27(2):103-104. PMID: 33830021.
      Citations:    Translation:Humans
    15. Chemaly RF, El Haddad L, Winston DJ, Rowley SD, Mulane KM, Chandrasekar P, Avery RK, Hari P, Peggs KS, Kumar D, Nath R, Ljungman P, Mossad SB, Dadwal SS, Blanchard T, Shah DP, Jiang Y, Ariza-Heredia E. Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study. Clin Infect Dis. 2020 12 03; 71(9):2365-2374. PMID: 32076709.
      Citations: 8     Fields:    Translation:HumansCells
    16. Ariza-Heredia EJ, Frenzel E, Cantu S, Carlson M, Thomas G, Khawaja F, Raad II, Chemaly RF. Surveillance and identification of clusters of healthcare workers with coronavirus disease 2019 (COVID-19): Multidimensional interventions at a comprehensive cancer center. Infect Control Hosp Epidemiol. 2021 07; 42(7):797-802. PMID: 33183368.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    17. Simmons SE, Carrion R, Alfson KJ, Staples HM, Jinadatha C, Jarvis WR, Sampathkumar P, Chemaly RF, Khawaja F, Povroznik M, Jackson S, Kaye KS, Rodriguez RM, Stibich MA. Deactivation of SARS-CoV-2 with pulsed-xenon ultraviolet light: Implications for environmental COVID-19 control. Infect Control Hosp Epidemiol. 2021 02; 42(2):127-130. PMID: 32741425.
      Citations: 15     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    18. ElGohary GM, Hashmi S, Styczynski J, Kharfan-Dabaja MA, Alblooshi RM, de la Cámara R, Mohmed S, Alshaibani A, Cesaro S, Abd El-Aziz N, Almaghrabi R, Gergis U, Majhail NS, El-Gohary Y, Chemaly RF, Aljurf M, El Fakih R. The risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis. Hematol Oncol Stem Cell Ther. 2020 Jul 30. PMID: 32745466.
      Citations: 25     Fields:    
    19. Waghmare A, Abidi MZ, Boeckh M, Chemaly RF, Dadwal S, El Boghdadly Z, Kamboj M, Papanicolaou GA, Pergam SA, Shahid Z. Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients. Biol Blood Marrow Transplant. 2020 11; 26(11):1983-1994. PMID: 32736007.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    20. Algwaiz G, Aljurf M, Koh M, Horowitz MM, Ljungman P, Weisdorf D, Saber W, Kodera Y, Szer J, Jawdat D, Wood WA, Brazauskas R, Lehmann L, Pasquini MC, Seber A, Lu PH, Atsuta Y, Riches M, Perales MA, Worel N, Okamoto S, Srivastava A, Chemaly RF, Cordonnier C, Dandoy CE, Wingard JR, Kharfan-Dabaja MA, Hamadani M, Majhail NS, Waghmare AA, Chao N, Kröger N, Shaw B, Mohty M, Niederwieser D, Greinix H, Hashmi SK. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee. Biol Blood Marrow Transplant. 2020 12; 26(12):2181-2189. PMID: 32717432.
      Citations: 15     Fields:    Translation:Humans
    21. Abudayyeh A, Lin H, Abdelrahim M, Rondon G, Andersson BS, Martinez CS, Page VD, Tarrand JJ, Kontoyiannis DP, Marin D, Oran B, Olson A, Jones R, Popat U, Champlin RE, Chemaly RF, Shpall EJ, Rezvani K. Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2020 Oct; 22(5):e13395. PMID: 32602954.
      Citations:    Fields:    Translation:HumansCells
    22. Malek AE, Gutierrez C, Mulanovich VE, Botdorf J, Chemaly RF, Shah S, McCall BM, Melancon JT, McConn KK, Borjan J, Raad II, Burger JA, Garcia-Manero G, Adachi JA. Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts. Mediterr J Hematol Infect Dis. 2020; 12(1):e2020044. PMID: 32670522.
      Citations: 2     
    23. Shigle TL, Handy VW, Chemaly RF. Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant. Ther Adv Hematol. 2020; 11:2040620720937150. PMID: 32637057.
      Citations: 3     
    24. Coomes EA, Al-Shamsi HO, Meyers BM, Alhazzani W, Alhuraiji A, Chemaly RF, Almuhanna M, Wolff RA, Ibrahim NK, Chua MLK, Hotte SJ, Elfiki T, Curigliano G, Eng C, Grothey A, Xie C. In Reply. Oncologist. 2020 08; 25(8):e1252-e1253. PMID: 32378772.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    25. Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, Wolff RA, Ibrahim NK, Chua MLK, Hotte SJ, Meyers BM, Elfiki T, Curigliano G, Eng C, Grothey A, Xie C. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 2020 06; 25(6):e936-e945. PMID: 32243668.
      Citations: 207     Fields:    Translation:HumansCellsPHPublic Health
    26. Ye X, Cabral de Rezende W, Iwuchukwu OP, Avadhanula V, Ferlic-Stark LL, Patel KD, Piedra FA, Shah DP, Chemaly RF, Piedra PA. Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (p27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Adult Hematopoietic Cell Transplant (HCT) Recipients. Vaccines (Basel). 2020 Apr 21; 8(2). PMID: 32326278.
      Citations: 2     
    27. Ljungman P, Schmitt M, Marty FM, Maertens J, Chemaly RF, Kartsonis NA, Butterton JR, Wan H, Teal VL, Sarratt K, Murata Y, Leavitt RY, Badshah C. A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation. Clin Infect Dis. 2020 04 10; 70(8):1525-1533. PMID: 31179485.
      Citations: 24     Fields:    Translation:HumansCellsCTClinical Trials
    28. Maertens J, Logan AC, Jang J, Long G, Tang JL, Hwang WYK, Koh LP, Chemaly R, Gerbitz A, Winkler J, Yeh SP, Hiemenz J, Christoph S, Lee DG, Wang PN, Holler E, Mielke S, Akard L, Yeo A, Ramachandra S, Smith K, Pertel P, Segal F. Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation. Antimicrob Agents Chemother. 2020 03 24; 64(4). PMID: 32015031.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    29. Alvarez-Cardona JJ, Whited LK, Chemaly RF. Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections. Future Microbiol. 2020 04; 15:389-400. PMID: 32166967.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    30. Cabrera NL, Malek AE, Shelburne S, Taremi M, Awadh H, Francisco D, Robins A, Jabbour E, Chemaly RF. Disseminated cytomegalovirus infection with bilateral adrenal pseudotumors masquerading as recurrent hematologic malignancy. Infection. 2020 Jun; 48(3):477-481. PMID: 32144592.
      Citations:    Fields:    Translation:HumansCells
    31. Fuentes S, Hahn M, Chilcote K, Chemaly RF, Shah DP, Ye X, Avadhanula V, Piedra PA, Golding H, Khurana S. Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans. J Infect Dis. 2020 02 03; 221(4):636-646. PMID: 31745552.
      Citations: 5     Fields:    Translation:HumansCells
    32. Marty FM, Ljungman PT, Chemaly RF, Wan H, Teal VL, Butterton JR, Yeh WW, Leavitt RY, Badshah CS. Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation. Am J Transplant. 2020 06; 20(6):1703-1711. PMID: 31883426.
      Citations: 8     Fields:    Translation:HumansCellsCTClinical Trials
    33. Sheshadri A, Godoy M, Erasmus JJ, Gruschkus S, Hasan A, Evans SE, Barreda-Garcia J, Chemaly RF, Dickey B, Ost D. Progression of the Radiologic Severity Index is associated with increased mortality and healthcare resource utilisation in acute leukaemia patients with pneumonia. BMJ Open Respir Res. 2019; 6(1):e000471. PMID: 31921429.
      Citations:    Translation:Humans
    34. Khawaja F, Batista MV, El Haddad L, Chemaly RF. Resistant or refractory cytomegalovirus infections after hematopoietic cell transplantation: diagnosis and management. Curr Opin Infect Dis. 2019 12; 32(6):565-574. PMID: 31567572.
      Citations: 3     Fields:    Translation:HumansCells
    35. Foolad F, Chemaly RF. Reply to Jain et al. Clin Infect Dis. 2019 11 27; 69(12):2235-2236. PMID: 31074774.
      Citations:    Fields:    Translation:Humans
    36. Magira EE, Chemaly RF, Jiang Y, Tarrand J, Kontoyiannis DP. Corrigendum: Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study. Open Forum Infect Dis. 2019 Nov; 6(11):ofz458. PMID: 31777755.
      Citations:    
    37. Kmeid J, Kulkarni PA, Batista MV, El Chaer F, Prayag A, Ariza-Heredia EJ, Mulanovich VE, Chemaly RF. Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006-2014. BMC Infect Dis. 2019 Nov 06; 19(1):934. PMID: 31694567.
      Citations: 1     Fields:    Translation:HumansCells
    38. El Haddad L, Ghantoji SS, Park AK, Batista MV, Schelfhout J, Hachem J, Lobo Y, Jiang Y, Rondon G, Champlin R, Chemaly RF. Clinical and economic burden of pre-emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients. J Med Virol. 2020 01; 92(1):86-95. PMID: 31448830.
      Citations: 5     Fields:    Translation:Humans
    39. Narula N, Lillemoe HA, Caudle AS, Chemaly RF, Anderson JJ, Segal C, Porter CA, Swisher SG, Levenback CF, Aloia TA. Postoperative Urinary Tract Infection Quality Assessment and Improvement: The S.T.O.P. UTI Program and Its Impact on Hospitalwide CAUTI Rates. Jt Comm J Qual Patient Saf. 2019 10; 45(10):686-693. PMID: 31371099.
      Citations:    Fields:    Translation:Humans
    40. Magira EE, Chemaly RF, Jiang Y, Tarrand J, Kontoyiannis DP. Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study. Open Forum Infect Dis. 2019 Jul; 6(7):ofz247. PMID: 31338382.
      Citations: 6     
    41. Khawaja F, Chemaly RF. Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies. Haematologica. 2019 07; 104(7):1322-1331. PMID: 31221784.
      Citations: 11     Fields:    Translation:HumansCells
    42. El Haddad L, Harb CP, Gebara MA, Stibich MA, Chemaly RF. A Systematic and Critical Review of Bacteriophage Therapy Against Multidrug-resistant ESKAPE Organisms in Humans. Clin Infect Dis. 2019 06 18; 69(1):167-178. PMID: 30395179.
      Citations: 27     Fields:    Translation:HumansCells
    43. Sheshadri A, Karimipour M, Vakil E, Bashoura L, Godoy M, Arain MH, Evans SE, Dickey BF, Ost DE, Chemaly RF, Faiz SA. Refinement of estimates of mortality risk using the Radiologic Severity Index in hematologic malignancy patients with respiratory syncytial virus infection. Transpl Infect Dis. 2019 Aug; 21(4):e13105. PMID: 31081570.
      Citations: 1     Fields:    Translation:Humans
    44. Foolad F, Aitken SL, Shigle TL, Prayag A, Ghantoji S, Ariza-Heredia E, Chemaly RF. Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients. Clin Infect Dis. 2019 05 02; 68(10):1641-1649. PMID: 30202920.
      Citations: 18     Fields:    Translation:HumansCells
    45. El Haddad L, Ariza-Heredia E, Chemaly RF. Reply to Giménez et al. J Infect Dis. 2019 04 16; 219(9):1512-1513. PMID: 30496440.
      Citations:    Fields:    Translation:HumansCells
    46. Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, Mullane KM, Kotton C, Lundgren J, Komatsu TE, Lischka P, Josephson F, Douglas CM, Umeh O, Miller V, Ljungman P. Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials. Clin Infect Dis. 2019 04 08; 68(8):1420-1426. PMID: 30137245.
      Citations: 24     Fields:    Translation:Humans
    47. Galloway-Peña JR, Peterson CB, Malik F, Sahasrabhojane PV, Shah DP, Brumlow CE, Carlin LG, Chemaly RF, Im JS, Rondon G, Felix E, Veillon L, Lorenzi PL, Alousi AM, Jenq RR, Kontoyiannis DP, Shpall EJ, Shelburne SA, Okhuysen PC. Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study. Open Forum Infect Dis. 2019 May; 6(5):ofz173. PMID: 31065565.
      Citations: 14     
    48. Kontoyiannis DP, Shah EC, Wurster S, Aitken SL, Graviss L, Raad II, Chemaly RF. Culture-Documented Invasive Mold Infections at MD Anderson Cancer Center in Houston, Texas, Pre- and Post-Hurricane Harvey. Open Forum Infect Dis. 2019 Apr; 6(4):ofz138. PMID: 31024975.
      Citations: 2     
    49. Ye X, Iwuchukwu OP, Avadhanula V, Aideyan LO, McBride TJ, Ferlic-Stark LL, Patel KD, Piedra FA, Shah DP, Chemaly RF, Piedra PA. Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults. Front Immunol. 2019; 10:706. PMID: 30984206.
      Citations: 6     Fields:    Translation:HumansCellsCTClinical Trials
    50. El Haddad L, Ariza-Heredia E, Shah DP, Jiang Y, Blanchard T, Ghantoji SS, El Chaer F, El-Haddad D, Prayag A, Nesher L, Rezvani K, Shpall E, Chemaly RF. The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients. J Infect Dis. 2019 02 23; 219(6):898-907. PMID: 30295846.
      Citations: 18     Fields:    Translation:HumansCells
    51. Ghobadi A, Milton DR, Gowda L, Rondon G, Chemaly RF, Hamdi A, Alousi A, Afrough A, Oran B, Ciurea S, Kebriaei P, Popat UR, Qazilbash MH, Shpall EJ, Champlin RE, Bashir Q. HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant. Curr Res Transl Med. 2019 05; 67(2):51-55. PMID: 30683577.
      Citations: 5     Translation:HumansCells
    52. Sheshadri A, Chemaly RF, Alousi AM, Shah PK, Rondon G, Bashoura L, Kmeid J, Azzi J, Blanco DW, Kaous M, Dickey BF, Champlin RE, Shah DP. Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant. 2019 04; 25(4):800-809. PMID: 30521974.
      Citations: 4     Fields:    Translation:Humans
    53. Batista MV, El Haddad L, Chemaly RF. Paramyxovirus infections in hematopoietic cell transplant recipients. Curr Opin Infect Dis. 2018 12; 31(6):542-552. PMID: 30320640.
      Citations: 1     Fields:    Translation:Humans
    54. Azzi JM, Kyvernitakis A, Shah DP, El Haddad L, Mahajan SN, Ghantoji SS, Heredia-Ariza E, Chemaly RF. Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection. J Antimicrob Chemother. 2018 11 01; 73(11):3162-3169. PMID: 30113677.
      Citations: 1     Fields:    Translation:Humans
    55. Marty FM, Winston DJ, Chemaly RF, Mullane KM, Shore TB, Papanicolaou GA, Chittick G, Brundage TM, Wilson C, Morrison ME, Foster SA, Nichols WG, Boeckh MJ. A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 02; 25(2):369-381. PMID: 30292744.
      Citations: 40     Fields:    Translation:HumansCellsCTClinical Trials
    56. Vakil E, Sheshadri A, Faiz SA, Shah DP, Zhu Y, Li L, Kmeid J, Azzi J, Balagani A, Bashoura L, Ariza-Heredia E, Chemaly RF. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies. Transpl Infect Dis. 2018 Dec; 20(6):e12994. PMID: 30195271.
      Citations: 12     Fields:    Translation:HumansCells
    57. Foolad F, Aitken SL, Chemaly RF. Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients. Expert Rev Clin Pharmacol. 2018 Oct; 11(10):931-941. PMID: 30004790.
      Citations: 3     Fields:    Translation:HumansCells
    58. Ye X, Iwuchukwu OP, Avadhanula V, Aideyan LO, McBride TJ, Ferlic-Stark LL, Patel KD, Piedra FA, Shah DP, Chemaly RF, Piedra PA. Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients. J Infect Dis. 2018 03 28; 217(8):1247-1256. PMID: 29365155.
      Citations: 8     Fields:    Translation:HumansCells
    59. Ariza-Heredia EJ, Chemaly RF, Shahani LR, Jang Y, Champlin RE, Mulanovich VE. Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study. Transpl Int. 2018 06; 31(6):639-648. PMID: 29464765.
      Citations: 3     Fields:    Translation:Humans
    60. Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, Haider S, Ullmann AJ, Katayama Y, Brown J, Mullane KM, Boeckh M, Blumberg EA, Einsele H, Snydman DR, Kanda Y, DiNubile MJ, Teal VL, Wan H, Murata Y, Kartsonis NA, Leavitt RY, Badshah C. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation. N Engl J Med. 2017 12 21; 377(25):2433-2444. PMID: 29211658.
      Citations: 179     Fields:    Translation:HumansCellsCTClinical Trials
    61. El Haddad L, Ghantoji SS, Stibich M, Fleming JB, Segal C, Ware KM, Chemaly RF. Evaluation of a pulsed xenon ultraviolet disinfection system to decrease bacterial contamination in operating rooms. BMC Infect Dis. 2017 10 10; 17(1):672. PMID: 29017457.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    62. Hammerstrom AE, Lombardi LR, Pingali SR, Rondon G, Chen J, Milton DR, Chemaly RF, Champlin RE, Gulbis A, Ciurea SO. Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018 02; 24(2):353-358. PMID: 28986189.
      Citations: 13     Fields:    Translation:Humans
    63. Vilar-Compte D, Shah DP, Vanichanan J, Cornejo-Juarez P, Garcia-Horton A, Volkow P, Chemaly RF. Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers. J Med Virol. 2018 01; 90(1):50-60. PMID: 28851056.
      Citations: 5     Fields:    Translation:Humans
    64. El Chaer F, Shah DP, Kmeid J, Ariza-Heredia EJ, Hosing CM, Mulanovich VE, Chemaly RF. Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes. Cancer. 2017 Jun 15; 123(12):2329-2337. PMID: 28178369.
      Citations: 9     Fields:    Translation:HumansCells
    65. Shahani L, Ariza-Heredia EJ, Chemaly RF. Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert Rev Anti Infect Ther. 2017 04; 15(4):401-415. PMID: 28067078.
      Citations: 10     Fields:    Translation:Humans
    66. Grimley MS, Chemaly RF, Englund JA, Kurtzberg J, Chittick G, Brundage TM, Bae A, Morrison ME, Prasad VK. Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial. Biol Blood Marrow Transplant. 2017 Mar; 23(3):512-521. PMID: 28063938.
      Citations: 32     Fields:    Translation:HumansCTClinical Trials
    67. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 29771962.
      Citations: 7     Fields:    Translation:HumansCells
    68. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 30677427.
      Citations: 17     Fields:    Translation:HumansCells
    69. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 29985544.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    70. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 30325760.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    71. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27885468.
      Citations: 4     Fields:    Translation:HumansCells
    72. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 31394271.
      Citations: 2     Fields:    Translation:Humans
    73. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 32536024.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    74. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 32844453.
      Citations: 2     Fields:    Translation:HumansCells
    75. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 33755273.
      Citations: 1     Fields:    Translation:Humans
    76. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 34452721.
      Citations:    Translation:Humans
    77. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 34124796.
      Citations: 1     Fields:    
    78. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 33929874.
      Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
    79. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 26612873.
      Citations: 2     Fields:    Translation:Humans
    80. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27862740.
      Citations: 3     Fields:    Translation:HumansCells
    81. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27313265.
      Citations: 21     Fields:    Translation:HumansCells
    82. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 24022408.
      Citations: 1     Fields:    Translation:Humans
    83. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 24529214.
      Citations: 13     Fields:    Translation:Humans
    84. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 23041818.
      Citations: 24     Fields:    Translation:Humans
    85. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 24327130.
      Citations: 9     Fields:    Translation:Humans
    86. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 24806159.
      Citations: 80     Fields:    Translation:HumansCTClinical Trials
    87. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 23307520.
      Citations: 10     Fields:    Translation:Humans
    88. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 23475503.
      Citations: 2     Fields:    Translation:HumansCells
    89. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 25164587.
      Citations: 5     Fields:    Translation:HumansCells
    90. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 25278398.
      Citations: 5     Fields:    Translation:Humans
    91. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 11811728.
      Citations:    Fields:    Translation:HumansCells
    92. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 23226621.
      Citations: 30     
    93. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 11941543.
      Citations: 21     Fields:    Translation:Humans
    94. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12944014.
      Citations: 12     Fields:    Translation:HumansCells
    95. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 11453074.
      Citations:    Fields:    Translation:HumansCells
    96. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12567321.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    97. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12578150.
      Citations: 5     Fields:    Translation:HumansAnimals
    98. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 14669300.
      Citations:    Fields:    Translation:HumansPHPublic Health
    99. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12733157.
      Citations: 18     Fields:    Translation:Humans
    100. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16310149.
      Citations: 63     Fields:    Translation:HumansAnimals
    101. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16974212.
      Citations: 90     Fields:    Translation:Humans
    102. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16609347.
      Citations: 6     Fields:    Translation:HumansCells
    103. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17530009.
      Citations: 37     Fields:    Translation:HumansCells
    104. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16767486.
      Citations: 18     Fields:    Translation:HumansAnimals
    105. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 18035197.
      Citations: 9     Fields:    Translation:Humans
    106. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 18004177.
      Citations: 15     Fields:    Translation:Humans
    107. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 18174198.
      Citations: 4     Fields:    Translation:Humans
    108. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17932828.
      Citations: 2     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    109. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19090003.
      Citations: 8     Fields:    Translation:HumansCells
    110. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19487050.
      Citations: 4     Fields:    Translation:HumansCells
    111. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19561648.
      Citations: 9     Fields:    Translation:Humans
    112. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15131185.
      Citations: 19     Fields:    Translation:HumansCells
    113. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19046167.
      Citations: 9     Fields:    Translation:HumansCells
    114. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21414843.
      Citations: 82     Fields:    Translation:HumansCTClinical Trials
    115. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 20837633.
      Citations: 13     Fields:    Translation:Humans
    116. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21862937.
      Citations: 6     Fields:    Translation:HumansCells
    117. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21492963.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    118. Liu X, Bian S, Zhang Y, Zhang L, Yang Q, Wang P, Xu Y, Shi X, Zhang Y, Chemaly RF. The characteristics of patients with mycobacterium tuberculosis blood stream infections in Beijing, China: a retrospective study. BMC Infect Dis. 2016 Dec 12; 16(1):750. PMID: 27955709.
      Citations: 1     Fields:    Translation:HumansCells
    119. El Chaer F, Shah DP, Chemaly RF. How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients. Blood. 2016 12 08; 128(23):2624-2636. PMID: 27760756.
      Citations: 34     Fields:    Translation:HumansCells
    120. El Chaer F, Mori N, Shah D, Oliver N, Wang E, Jan A, Doan V, Tverdek F, Tayar J, Ariza-Heredia E, Chemaly RF. Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series. Antiviral Res. 2016 11; 135:91-96. PMID: 27594527.
      Citations: 3     Fields:    Translation:HumansCells
    121. El-Haddad D, El Chaer F, Vanichanan J, Shah DP, Ariza-Heredia EJ, Mulanovich VE, Gulbis AM, Shpall EJ, Chemaly RF. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience. Antiviral Res. 2016 10; 134:58-62. PMID: 27582067.
      Citations: 7     Fields:    Translation:HumansCells
    122. Langman LJ, Nesher L, Shah DP, Azzi JM, Shpall EJ, Rezvani K, Black JL, Chemaly RF. Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients. J Mol Diagn. 2016 09; 18(5):638-642. PMID: 27371869.
      Citations: 1     Fields:    Translation:Humans
    123. Shah DP, Shah PK, Azzi JM, El Chaer F, Chemaly RF. Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review. Cancer Lett. 2016 08 28; 379(1):100-6. PMID: 27260872.
      Citations: 20     Fields:    Translation:HumansCells
    124. Frenzel E, Chemaly RF, Ariza-Heredia E, Jiang Y, Shah DP, Thomas G, Graviss L, Raad I. Association of increased influenza vaccination in health care workers with a reduction in nosocomial influenza infections in cancer patients. Am J Infect Control. 2016 09 01; 44(9):1016-21. PMID: 27158088.
      Citations: 15     Fields:    Translation:HumansPHPublic Health
    125. Kimball LE, Stevens-Ayers T, Green ML, Xie H, Flowers ME, Jerome KR, LeBlanc R, Dahlgren C, Nichols WG, Chemaly RF, Papanicolaou G, Boeckh M. A MULTICENTER, LONGITUDINAL, INTERVENTIONAL, DOUBLE BLIND RANDOMIZED CLINICAL TRIAL IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RESIDING IN REMOTE AREAS: LESSONS LEARNED FROM THE LATE CYTOMEGALOVIRUS PREVENTION TRIAL. Contemp Clin Trials Commun. 2016 Dec 15; 4:84-89. PMID: 28184381.
      Citations:    
    126. Galloway-Peña JR, Smith DP, Sahasrabhojane P, Ajami NJ, Wadsworth WD, Daver NG, Chemaly RF, Marsh L, Ghantoji SS, Pemmaraju N, Garcia-Manero G, Rezvani K, Alousi AM, Wargo JA, Shpall EJ, Futreal PA, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer. 2016 07 15; 122(14):2186-96. PMID: 27142181.
      Citations: 47     Fields:    Translation:Humans
    127. Nesher L, Shah DP, Ariza-Heredia EJ, Azzi JM, Siddiqui HK, Ghantoji SS, Marsh LY, Michailidis L, Makedonas G, Rezvani K, Shpall EJ, Chemaly RF. Utility of the Enzyme-Linked Immunospot Interferon-?-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients. J Infect Dis. 2016 Jun 01; 213(11):1701-7. PMID: 26908740.
      Citations: 19     Fields:    Translation:HumansCellsCTClinical Trials
    128. Kmeid J, Vanichanan J, Shah DP, El Chaer F, Azzi J, Ariza-Heredia EJ, Hosing C, Mulanovich V, Chemaly RF. Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index. Biol Blood Marrow Transplant. 2016 Mar; 22(3):542-8. PMID: 26638804.
      Citations: 20     Fields:    Translation:HumansCellsCTClinical Trials
    129. Shah DP, Shah PK, Azzi JM, Chemaly RF. Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review. Cancer Lett. 2016 Jan 28; 370(2):358-64. PMID: 26582658.
      Citations: 33     Fields:    Translation:Humans
    130. Shelburne SA, Ajami NJ, Chibucos MC, Beird HC, Tarrand J, Galloway-Peña J, Albert N, Chemaly RF, Ghantoji SS, Marsh L, Pemmaraju N, Andreeff M, Shpall EJ, Wargo JA, Rezvani K, Alousi A, Bruno VM, Futreal PA, Petrosino JF, Kontoyiannis DP. Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis. PLoS One. 2015; 10(11):e0139851. PMID: 26556047.
      Citations: 22     Fields:    Translation:HumansAnimals
    131. Chemaly RF, Ghantoji SS, Huber T, Raad II, Jinadatha C, Stibich M. Innovative Analysis of the Sequenced Patterns of Vancomycin-Resistant Enterococci Strains to Determine Clonal Transmission in a Hospital Setting. Infect Control Hosp Epidemiol. 2015 Dec; 36(12):1461-3. PMID: 26329908.
      Citations: 1     Fields:    Translation:HumansCells
    132. Ariza-Heredia EJ, Azzi J, Shah DP, Nesher L, Ghantoji SS, Michailidis L, Marsh L, Chemaly RF. Influenza vaccination in patients with cancer: factors associated with vaccination practices for patients and their household members. Infect Control Hosp Epidemiol. 2015 Oct; 36(10):1239-41. PMID: 26132392.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    133. Ariza-Heredia EJ, Chemaly RF. Practical review of immunizations in adult patients with cancer. Hum Vaccin Immunother. 2015; 11(11):2606-14. PMID: 26110220.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    134. Saliba RM, Rezvani K, Leen A, Jorgensen J, Shah N, Hosing C, Parmar S, Oran B, Olson A, Rondon G, Chen J, Martinez C, Hamdi A, Mehta RS, Chemaly RF, Saunders IM, Bollard CM, Shpall EJ. General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation. Biol Blood Marrow Transplant. 2015 Jul; 21(7):1284-90. PMID: 25708219.
      Citations: 22     Fields:    Translation:HumansCells
    135. Ghantoji SS, Stibich M, Stachowiak J, Cantu S, Adachi JA, Raad II, Chemaly RF. Non-inferiority of pulsed xenon UV light versus bleach for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile infection isolation rooms. J Med Microbiol. 2015 Feb; 64(Pt 2):191-4. PMID: 25627208.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    136. Boeckh M, Nichols WG, Chemaly RF, Papanicolaou GA, Wingard JR, Xie H, Syrjala KL, Flowers ME, Stevens-Ayers T, Jerome KR, Leisenring W. Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial. Ann Intern Med. 2015 Jan 06; 162(1):1-10. PMID: 25560711.
      Citations: 33     Fields:    Translation:HumansCells
    137. Saunders IM, Lahoti A, Chemaly RF, Trevino C, Westmoreland M, Hosing C. Topical cidofovir-induced acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections. J Oncol Pharm Pract. 2016 Apr; 22(2):325-31. PMID: 25488905.
      Citations: 2     Fields:    Translation:Humans
    138. Ariza-Heredia EJ, Gulbis AM, Stolar KR, Kebriaei P, Shah DP, McConn KK, Champlin RE, Chemaly RF. Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice. Transpl Infect Dis. 2014 Dec; 16(6):878-86. PMID: 25405922.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    139. Chemaly RF, Shah DP, Boeckh MJ. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014 Nov 15; 59 Suppl 5:S344-51. PMID: 25352629.
      Citations: 61     Fields:    Translation:Humans
    140. Chemaly RF, Dantes R, Shah DP, Shah PK, Pascoe N, Ariza-Heredia E, Perego C, Nguyen DB, Nguyen K, Modarai F, Moulton-Meissner H, Noble-Wang J, Tarrand JJ, LiPuma JJ, Guh AY, MacCannell T, Raad I, Mulanovich V. Cluster and sporadic cases of herbaspirillum species infections in patients with cancer. Clin Infect Dis. 2015 Jan 01; 60(1):48-54. PMID: 25216687.
      Citations: 5     Fields:    Translation:HumansCells
    141. Ariza-Heredia EJ, Chemaly RF. Infection control practices in patients with hematological malignancies and multidrug-resistant organisms: special considerations and challenges. Clin Lymphoma Myeloma Leuk. 2014 Sep; 14 Suppl:S104-10. PMID: 25486947.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    142. Avadhanula V, Chemaly RF, Shah DP, Ghantoji SS, Azzi JM, Aideyan LO, Mei M, Piedra PA. Infection with novel respiratory syncytial virus genotype Ontario (ON1) in adult hematopoietic cell transplant recipients, Texas, 2011-2013. J Infect Dis. 2015 Feb 15; 211(4):582-9. PMID: 25156562.
      Citations: 18     Fields:    Translation:HumansCells
    143. Chemaly RF, Ullmann AJ, Ehninger G. CMV prophylaxis in hematopoietic-cell transplantation. N Engl J Med. 2014 08 07; 371(6):576-7. PMID: 25099585.
      Citations: 4     Fields:    Translation:Humans
    144. Chemaly RF, Simmons S, Dale C, Ghantoji SS, Rodriguez M, Gubb J, Stachowiak J, Stibich M. The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containment. Ther Adv Infect Dis. 2014 Jun; 2(3-4):79-90. PMID: 25469234.
      Citations: 32     
    145. Haynes AB, Bloom ES, Bedrosian I, Kuerer HM, Hwang RF, Munsell MF, Chemaly RF, Graviss LS, Caudle AS, Hunt KK, Tereffe W, Shaitelman SF, Babiera GV. Timing of infectious complications following breast-conserving therapy with catheter-based accelerated partial breast irradiation. Ann Surg Oncol. 2014 Aug; 21(8):2512-6. PMID: 24736987.
      Citations: 1     Fields:    Translation:Humans
    146. Shah DP, Ghantoji SS, Ariza-Heredia EJ, Shah JN, El Taoum KK, Shah PK, Nesher L, Hosing C, Rondon G, Champlin RE, Chemaly RF. Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections. Blood. 2014 May 22; 123(21):3263-8. PMID: 24700783.
      Citations: 37     Fields:    Translation:HumansCells
    147. Mahajan SN, Ariza-Heredia EJ, Rolston KV, Graviss LS, Feig BW, Aloia TA, Chemaly RF. Perioperative antimicrobial prophylaxis for intra-abdominal surgery in patients with cancer: a retrospective study comparing ertapenem and nonertapenem antibiotics. Ann Surg Oncol. 2014 Feb; 21(2):513-9. PMID: 24114052.
      Citations: 8     Fields:    Translation:Humans
    148. Ariza-Heredia EJ, Nesher L, Chemaly RF. Cytomegalovirus diseases after hematopoietic stem cell transplantation: a mini-review. Cancer Lett. 2014 Jan 01; 342(1):1-8. PMID: 24041869.
      Citations: 43     Fields:    Translation:HumansCells
    149. Shah DP, Munsell MF, Chemaly RF. Reply to Robinson. J Infect Dis. 2013 Sep 01; 208(5):864-5. PMID: 23812046.
      Citations:    Fields:    Translation:HumansCells
    150. Shah DP, Ghantoji SS, Shah JN, El Taoum KK, Jiang Y, Popat U, Hosing C, Rondon G, Tarrand JJ, Champlin RE, Chemaly RF. Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections. J Antimicrob Chemother. 2013 Aug; 68(8):1872-80. PMID: 23572228.
      Citations: 48     Fields:    Translation:Humans
    151. Yilmaz M, Chemaly RF, Han XY, Thall PF, Fox PS, Tarrand JJ, De Lima MJ, Hosing CM, Popat UR, Shpall E, Champlin RE, Qazilbash MH. Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience. Bone Marrow Transplant. 2013 Sep; 48(9):1218-23. PMID: 23503529.
      Citations: 9     Fields:    Translation:HumansCells
    152. Munsell MF, Shah DP, Chemaly RF. Reply to Fätkenheuer et al. J Infect Dis. 2013 May 15; 207(10):1622-3. PMID: 23444011.
      Citations:    Fields:    Translation:HumansCells
    153. Chemaly RF, Torres HA, Munsell MF, Shah DP, Rathod DB, Bodey GP, Hosing C, Saifan C, Raad II, Champlin RE. An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection. J Infect Dis. 2012 Nov; 206(9):1367-71. PMID: 22927454.
      Citations: 13     Fields:    Translation:HumansCells
    154. Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Hwang JP, Davila M, Torres HA. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol. 2012 Dec; 57(6):1177-85. PMID: 22871500.
      Citations: 36     Fields:    Translation:HumansCells
    155. Mahajan SN, Shah JN, Hachem R, Tverdek F, Adachi JA, Mulanovich V, Rolston KV, Raad II, Chemaly RF. Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist. 2012; 17(10):1329-36. PMID: 22707509.
      Citations: 12     Fields:    Translation:HumansCells
    156. Shah DP, El Taoum KK, Shah JN, Vigil KJ, Adachi JA, Granwehr BP, Tarrand JJ, Raad II, Chemaly RF. Characteristics and outcomes of pandemic 2009/H1N1 versus seasonal influenza in children with cancer. Pediatr Infect Dis J. 2012 Apr; 31(4):373-8. PMID: 22228234.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    157. Chemaly RF, Vigil KJ, Saad M, Vilar-Compte D, Cornejo-Juarez P, Perez-Jimenez C, Mubarak S, Salhab M, Jiang Y, Granwehr B, Adachi JA, Raad II. A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries: early therapy improves outcomes. Cancer. 2012 Sep 15; 118(18):4627-33. PMID: 22359314.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
    158. Chemaly RF, Hanmod SS, Rathod DB, Ghantoji SS, Jiang Y, Doshi A, Vigil K, Adachi JA, Khoury AM, Tarrand J, Hosing C, Champlin R. The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation. Blood. 2012 Mar 22; 119(12):2738-45; quiz 2969. PMID: 22246027.
      Citations: 38     Fields:    Translation:Humans
    159. Anaya DA, Cormier JN, Xing Y, Koller P, Gaido L, Hadfield D, Chemaly RF, Feig BW. Development and validation of a novel stratification tool for identifying cancer patients at increased risk of surgical site infection. Ann Surg. 2012 Jan; 255(1):134-9. PMID: 22143206.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    160. Rolston KV, Mahajan SN, Chemaly RF. Antimicrobial de-escalation in cancer patients. Infection. 2012 Apr; 40(2):223-4; author reply 229-30. PMID: 22090318.
      Citations: 2     Fields:    Translation:Humans
    161. Chemaly RF, Ghantoji SS, Stibich M. Novel intervention for eliminating VRE from the environment. Arch Intern Med. 2011 Oct 10; 171(18):1684-5. PMID: 21987202.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    162. Raval M, Gulbis A, Bollard C, Leen A, Chemaly R, Shpall E, Lahoti A, Kebriaei P. Evaluation and management of BK virus-associated nephropathy following allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2011 Nov; 17(11):1589-93. PMID: 21767514.
      Citations: 7     Fields:    Translation:HumansCells
    163. Stibich M, Stachowiak J, Tanner B, Berkheiser M, Moore L, Raad I, Chemaly RF. Evaluation of a pulsed-xenon ultraviolet room disinfection device for impact on hospital operations and microbial reduction. Infect Control Hosp Epidemiol. 2011 Mar; 32(3):286-8. PMID: 21460515.
      Citations: 15     Fields:    Translation:CellsPHPublic Health
    164. Kassis C, Hachem R, Raad II, Perego CA, Dvorak T, Hulten KG, Frenzel E, Thomas G, Chemaly RF. Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among health care workers in a cancer center. Am J Infect Control. 2011 Mar; 39(2):112-7. PMID: 20817317.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    165. Ramos ER, Reitzel R, Jiang Y, Hachem RY, Chaftari AM, Chemaly RF, Hackett B, Pravinkumar SE, Nates J, Tarrand JJ, Raad II. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med. 2011 Feb; 39(2):245-51. PMID: 21057308.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    166. Shah JN, Chemaly RF. Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood. 2011 Mar 10; 117(10):2755-63. PMID: 21139081.
      Citations: 75     Fields:    Translation:HumansAnimals
    167. Vigil KJ, Chemaly RF. Valacyclovir: approved and off-label uses for the treatment of herpes virus infections in immunocompetent and immunocompromised adults. Expert Opin Pharmacother. 2010 Aug; 11(11):1901-13. PMID: 20536295.
      Citations: 3     Fields:    Translation:Humans
    168. Chaftari AM, Hachem R, Mulanovich V, Chemaly RF, Adachi J, Jacobson K, Jiang Y, Raad I. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents. 2010 Aug; 36(2):182-6. PMID: 20452752.
      Citations: 10     Fields:    Translation:Humans
    169. Kassis C, Champlin RE, Hachem RY, Hosing C, Tarrand JJ, Perego CA, Neumann JL, Raad II, Chemaly RF. Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab. Biol Blood Marrow Transplant. 2010 Sep; 16(9):1265-71. PMID: 20304082.
      Citations: 26     Fields:    Translation:HumansPHPublic Health
    170. Chemaly RF, Hachem RY, Husni RN, Bahna B, Abou Rjaili G, Rjaili GA, Waked A, Graviss L, Nebiyou Bekele B, Shah JN, Raad II. Characteristics and outcomes of methicillin-resistant Staphylococcus aureus surgical-site infections in patients with cancer: a case-control study. Ann Surg Oncol. 2010 Jun; 17(6):1499-506. PMID: 20127184.
      Citations: 9     Fields:    Translation:HumansCells
    171. Chemaly RF, Sharma PS, Youssef S, Gerber D, Hwu P, Hanmod SS, Jiang Y, Hachem RY, Raad II. The efficacy of catheters coated with minocycline and rifampin in the prevention of catheter-related bacteremia in cancer patients receiving high-dose interleukin-2. Int J Infect Dis. 2010 Jul; 14(7):e548-52. PMID: 20005762.
      Citations: 4     Fields:    Translation:Humans
    172. Chemaly RF, Rathod DB, Raad II. A tertiary care cancer center experience of the 2007 outbreak of Serratia marcescens bloodstream infection due to prefilled syringes. Infect Control Hosp Epidemiol. 2009 Dec; 30(12):1237-8. PMID: 19888846.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    173. Blossom D, Noble-Wang J, Su J, Pur S, Chemaly R, Shams A, Jensen B, Pascoe N, Gullion J, Casey E, Hayden M, Arduino M, Budnitz DS, Raad I, Trenholme G, Srinivasan A. Multistate outbreak of Serratia marcescens bloodstream infections caused by contamination of prefilled heparin and isotonic sodium chloride solution syringes. Arch Intern Med. 2009 Oct 12; 169(18):1705-11. PMID: 19822828.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    174. Chemaly RF, Hanmod SS, Jiang Y, Rathod DB, Mulanovich V, Adachi JA, Rolston KV, Raad II, Hachem RY. Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution. Medicine (Baltimore). 2009 Jul; 88(4):211-220. PMID: 19593226.
      Citations: 14     Fields:    Translation:Humans
    175. Georgescu G, Chemaly RF. Palivizumab: where to from here? Expert Opin Biol Ther. 2009 Jan; 9(1):139-47. PMID: 19063700.
      Citations: 9     Fields:    Translation:HumansAnimals
    176. Adachi JA, Perego C, Graviss L, Dvorak T, Hachem R, Chemaly RF, Raad II. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients. Am J Infect Control. 2009 Aug; 37(6):442-6. PMID: 19118923.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    177. Vigil KJ, Mulanovich VE, Chemaly RF, Tarrand J, Raad II, Adachi JA. Severe parainfluenza virus type 2 supraglottitis in an immunocompetent adult host: an unusual cause of a paramyxoviridae viral infection. J Intern Med. 2009 Mar; 265(3):397-400. PMID: 19019183.
      Citations:    Fields:    Translation:HumansCells
    178. Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol. 2009 Jan; 47(1):129-33. PMID: 19005145.
      Citations: 51     Fields:    Translation:Humans
    179. Ghanem G, Hachem RY, Chemaly RF, Dvorak T, Hulten K, Graviss L, Raad II. The role of molecular methods in the prevention of nosocomial methicillin-resistant Staphylococcus aureus clusters in cancer patients. Am J Infect Control. 2008 Nov; 36(9):656-60. PMID: 18834742.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    180. Raad I, Reitzel R, Jiang Y, Chemaly RF, Dvorak T, Hachem R. Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria. J Antimicrob Chemother. 2008 Oct; 62(4):746-50. PMID: 18653489.
      Citations: 13     Fields:    Translation:CellsPHPublic Health
    181. Winston DJ, Young JA, Pullarkat V, Papanicolaou GA, Vij R, Vance E, Alangaden GJ, Chemaly RF, Petersen F, Chao N, Klein J, Sprague K, Villano SA, Boeckh M. Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study. Blood. 2008 Jun 01; 111(11):5403-10. PMID: 18285548.
      Citations: 55     Fields:    Translation:Humans
    182. Lamaris GA, Esmaeli B, Chamilos G, Desai A, Chemaly RF, Raad II, Safdar A, Lewis RE, Kontoyiannis DP. Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis. 2008 May; 27(5):343-7. PMID: 18183439.
      Citations: 15     Fields:    Translation:HumansAnimals
    183. Chemaly RF, Torres HA, Hachem R, Kontoyiannis DP, Safdar A, Raad II. Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection. Haematologica. 2008 Jan; 93(1):157-8. PMID: 18166808.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    184. Torres HA, Chemaly RF. Viral infection or reactivation in patients during treatment with dasatinib: a call for screening? Leuk Lymphoma. 2007 Dec; 48(12):2308-9. PMID: 18067004.
      Citations: 3     Fields:    Translation:HumansCells
    185. Raad I, Hachem R, Hanna H, Bahna P, Chatzinikolaou I, Fang X, Jiang Y, Chemaly RF, Rolston K. Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis. 2007 Aug; 26(8):549-56. PMID: 17582536.
      Citations: 15     Fields:    Translation:Humans
    186. Torres HA, Aguilera EA, Mattiuzzi GN, Cabanillas ME, Rohatgi N, Sepulveda CA, Kantarjian HM, Jiang Y, Safdar A, Raad II, Chemaly RF. Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia. Haematologica. 2007 Sep; 92(9):1216-23. PMID: 17666367.
      Citations: 16     Fields:    Translation:HumansCells
    187. Ghanem G, Hachem R, Jiang Y, Chemaly RF, Raad I. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Infect Control Hosp Epidemiol. 2007 Sep; 28(9):1054-9. PMID: 17932826.
      Citations: 18     Fields:    Translation:HumansCells
    188. Sims CR, Thompson K, Chemaly RF, Shpall EJ, Champlin RE, Safdar A. Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection. Transpl Infect Dis. 2007 Sep; 9(3):256-9. PMID: 17605730.
      Citations: 3     Fields:    Translation:HumansCells
    189. Hachem RY, Chemaly RF, Ahmar CA, Jiang Y, Boktour MR, Rjaili GA, Bodey GP, Raad II. Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients. Antimicrob Agents Chemother. 2007 Jun; 51(6):1905-11. PMID: 17387153.
      Citations: 29     Fields:    Translation:HumansCells
    190. Chemaly RF, Torres HA, Aguilera EA, Mattiuzzi G, Cabanillas M, Kantarjian H, Gonzalez V, Safdar A, Raad II. Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study. Clin Infect Dis. 2007 Apr 01; 44(7):964-7. PMID: 17342649.
      Citations: 16     Fields:    Translation:Humans
    191. Kumashi PR, Safdar A, Chamilos G, Chemaly RF, Raad II, Kontoyiannis DP. Fungal osteoarticular infections in patients treated at a comprehensive cancer centre: a 10-year retrospective review. Clin Microbiol Infect. 2006 Jul; 12(7):621-6. PMID: 16774557.
      Citations: 7     Fields:    Translation:Humans
    192. Chamilos G, Luna M, Lewis RE, Bodey GP, Chemaly R, Tarrand JJ, Safdar A, Raad II, Kontoyiannis DP. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica. 2006 Jul; 91(7):986-9. PMID: 16757415.
      Citations: 121     Fields:    Translation:Humans
    193. Torres HA, Kontoyiannis DP, Aguilera EA, Younes A, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma. 2006 Mar; 6(5):393-8. PMID: 16640816.
      Citations: 9     Fields:    Translation:Humans
    194. Torres HA, Hanna HA, Graviss L, Chaiban G, Hachem R, Chemaly RF, Girgawy E, Raad II. Chest tube-related empyema due to methicillin-resistant Staphylococcus aureus: could the chest tube be coated with antiseptics? Infect Control Hosp Epidemiol. 2006 Feb; 27(2):195-7. PMID: 16465639.
      Citations:    Fields:    Translation:HumansCells
    195. Aisenberg GM, Jacobson K, Chemaly RF, Rolston KV, Raad II, Safdar A. Extrapulmonary tuberculosis active infection misdiagnosed as cancer: Mycobacterium tuberculosis disease in patients at a Comprehensive Cancer Center (2001-2005). Cancer. 2005 Dec 15; 104(12):2882-7. PMID: 16245341.
      Citations: 10     Fields:    Translation:HumansCells
    196. Chemaly RF, Torres HA, Hachem RY, Nogueras GM, Aguilera EA, Younes A, Luna MA, Rodriguez G, Tarrand JJ, Raad II. Cytomegalovirus pneumonia in patients with lymphoma. Cancer. 2005 Sep 15; 104(6):1213-20. PMID: 16078263.
      Citations: 8     Fields:    Translation:Humans
    197. Torres HA, Kontoyiannis DP, Bodey GP, Adachi JA, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer. 2005 Oct; 41(15):2268-79. PMID: 16143517.
      Citations: 8     Fields:    Translation:Humans
    198. Chemaly RF, Yen-Lieberman B, Chapman J, Reilly A, Bekele BN, Gordon SM, Procop GW, Shrestha N, Isada CM, Decamp M, Avery RK. Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients. Am J Transplant. 2005 Mar; 5(3):544-8. PMID: 15707409.
      Citations: 14     Fields:    Translation:HumansCells
    199. Chemaly RF, Yen-Lieberman B, Schindler SA, Goldfarb J, Hall GS, Procop GW. Rotaviral and bacterial gastroenteritis in children during winter: an evaluation of physician ordering patterns. J Clin Virol. 2003 Sep; 28(1):44-50. PMID: 12927750.
      Citations: 2     Fields:    Translation:HumansCells
    200. Chemaly RF, Fox SB, Alkotob LM, Scharpf J, Sobecks R, Eliachar I, Procop GW, Smith M, Avery RK, Schmitt SK. A case of zygomycosis and invasive candidiasis involving the epiglottis and tongue in an immunocompromised patient. Scand J Infect Dis. 2002; 34(2):149-51. PMID: 11928855.
      Citations: 1     Fields:    Translation:HumansAnimals
    201. Chemaly RF, Tomford JW, Hall GS, Sholtis M, Chua JD, Procop GW. Rapid diagnosis of Histoplasma capsulatum endocarditis using the AccuProbe on an excised valve. J Clin Microbiol. 2001 Jul; 39(7):2640-1. PMID: 11427583.
      Citations: 8     Fields:    Translation:HumansAnimals
    202. Huang YW, Hamilton A, Arnuk OJ, Chaftari P, Chemaly R. Current drug therapy for multiple myeloma. Drugs. 1999 Apr; 57(4):485-506. PMID: 10235689.
      Citations: 1     Fields:    Translation:Humans
    203. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients. Transplant Infectious Disease.
    204. Ertapenem usage in cancer patients with and without neutropenia. Infection.
    205. Implementation of a pan-genomic approach to investigate holobiont-infecting microbe interaction. PLoS One. 10.
    206. Utility of the enzyme-linked immunospot interferon-γ- release assay to predict the risk of cytomegalovirus infection in hematopoietic cell transplant recipients. Journal of Infectious Diseases. 213:1701-1707.
    207. Innovative analysis of the sequenced patterns of Vancomycin-Resistant enterococci strains to determine clonal transmission in a hospital setting. Infection Control and Hospital Epidemiology. 36:1461-1463.
    208. Topical cidofovir-induced acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections. Journal of Oncology Pharmacy Practice. 22:325-331.
    209. The role of the healthcare environment in the spread of multidrug-resistant organisms. Therapeutic Advances in Infectious Disease. 2:79-90.
    210. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients. Antiviral Research. 134:58-62.
    211. Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients. Journal of Molecular Diagnostics. 18:638-642.
    212. Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients. Journal of Antimicrobial Chemotherapy. 71:727-730.
    213. Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients. Cancer Letters.
    214. High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center. Clinical Infectious Diseases. 63:954-958.
    215. Staphylococcus lugdunensis infections, filling in the gaps. Supportive Care in Cancer. 1-7.
    216. Association of increased influenza vaccination in health care workers with a reduction in nosocomial influenza infections in cancer patients. American Journal of Infection Control.
    217. General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation. Biology of Blood and Marrow Transplantation. 21:1284-1290.
    218. Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients. Biology of Blood and Marrow Transplantation.
    219. Practical review of immunizations in adult patients with cancer. Human Vaccines and Immunotherapeutics. 11:2606-2614.
    220. Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients. Antiviral Research. 135:91-96.
    221. Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients. American Journal of Transplantation.
    222. The impact of pre-transplant valganciclovir on early cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation. Journal of Oncology Pharmacy Practice. 20:257-262.
    223. Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients. Biology of Blood and Marrow Transplantation. 23:512-521.
    224. A multicenter, longitudinal, interventional, double blind randomized clinical trial in hematopoietic cell transplant recipients residing in remote areas. Contemporary Clinical Trials Communications. 4:84-89.
    225. Non-inferiority of pulsed xenon UV light versus bleach for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile infection isolation rooms. Journal of Medical Microbiology. 64:191-194.
    226. Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients. Cancer Letters. 379:100-106.
    227. The characteristics of patients with mycobacterium tuberculosis blood stream infections in Beijing, China. BMC Infectious Diseases. 16.
    228. Erratum. Annals of Surgical Oncology. 18.
    229. Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation. Transplant Infectious Disease. 17:33-38.
    CHEMALY's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (597)
    Explore
    _
    Co-Authors (107)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _